8-K//Current report
Ingevity Corp 8-K
Accession 0001493152-26-000248
$NGVTCIK 0001653477operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:39 AM ET
Size
2.7 MB
Accession
0001493152-26-000248
Research Summary
AI-generated summary of this filing
Ingevity Corp Completes Asset Sale of Industrial Specialties and Refinery
What Happened
- Ingevity Corporation announced it completed the disposition required by an Asset Purchase Agreement: on January 1, 2026 Buyer Mainstream Pine Products, LLC purchased substantially all assets and assumed certain rights and liabilities related to (a) Ingevity’s industrial specialties product line (with specified exceptions) and (b) Ingevity’s North Charleston, South Carolina crude tall oil refinery and related operations.
- Concurrently on January 1, 2026 the parties executed a First Amendment to the Asset Purchase Agreement that narrowed the scope of assets being transferred by excluding non‑lignin dispersant products sold to existing customers for agricultural chemical applications. The original Purchase Agreement was dated September 3, 2025 and remains in effect except as amended.
Key Details
- Closing and Amendment date: January 1, 2026.
- Buyer: Mainstream Pine Products, LLC (per the Asset Purchase Agreement filed Sept 3, 2025).
- Assets sold: substantially all assets related to Ingevity’s industrial specialties product line (subject to enumerated exceptions) and the North Charleston, SC crude tall oil refinery and its operations.
- Amendment effect: excludes non‑lignin dispersant products sold to existing agricultural chemical customers from the transferred assets.
- Press release announcing the transaction was filed as Exhibit 99.1 on January 5, 2026.
Why It Matters
- This filing reports a completed, material disposition of key operating assets—changes that can affect Ingevity’s revenue mix, operations and asset base.
- The amendment narrows what was sold by carving out certain agricultural dispersant products, which may preserve related customer relationships or revenue streams for Ingevity.
- The 8‑K does not disclose purchase price or detailed financial impacts; investors should review the press release and future filings for financial effects and management commentary.
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-2.2ex2-2.htm
EX-2.2
- EX-99.1ex99-1.htm
EX-99.1
- GRAPHICform8-k_001.jpg
GRAPHIC
- GRAPHICex2-2_001.jpg
GRAPHIC
- GRAPHICex2-2_002.jpg
GRAPHIC
- GRAPHICex2-2_003.jpg
GRAPHIC
- GRAPHICex2-2_004.jpg
GRAPHIC
- GRAPHICex99-1_001.jpg
GRAPHIC
- EX-101.SCHngvt-20260101.xsd
XBRL SCHEMA FILE
- EX-101.LABngvt-20260101_lab.xml
XBRL LABEL FILE
- EX-101.PREngvt-20260101_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001493152-26-000248-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Ingevity Corp
CIK 0001653477
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001653477
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:39 AM ET
- Size
- 2.7 MB